Average Insider

Where insiders trade, we follow

$ORKA
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
Healthcare
Sector
Biotechnology
Industry
Lawrence Otto Klein
CEO
28
Employees
$86.65
Current Price
$34.82M
Market Cap
52W Low$12.84
Current$86.6586.9% above low, 13.1% below high
52W High$97.78

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00--All Sells
Sells28$1,450,117.9816,999
2 weeksBuys00--All Sells
Sells28$1,450,117.9816,999
1 monthBuys00--All Sells
Sells414$302,065,071.093,576,996
2 monthsBuys00--All Sells
Sells730$312,161,852.403,737,859
3 monthsBuys00--All Sells
Sells743$313,521,978.133,760,149
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
May 1, 2026
Sandler Laura Lee
Chief Operating Officer
Sale400$66.06$26,422.00View Details
May 1, 2026
Sandler Laura Lee
Chief Operating Officer
Sale300$65.10$19,530.00View Details
May 1, 2026
Sandler Laura Lee
Chief Operating Officer
Sale2,200$62.58$137,685.46View Details
24 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.

Related Activity

Cross-company insider connections and cluster buy signals
Version: v26.7.3